I.W.G Inc., a Tokyo-based healthtech startup, has raised US$1.8 million in a pre-Series A round led by Golden Gate Ventures, with participation from Antler and individual backers, including radiologist-entrepreneur Dr Toshihiko Sato.
The funding will be used to scale an AI-driven interoperability platform that maps and routes clinical data across incompatible hospital systems and languages, a problem that is particularly acute across Southeast Asia and Greater China.
Also Read: The most-funded healthtech startups in Southeast Asia: A decade in review
The round is notable for being the first Japanese investment from Golden Gate Ventures Fund IV, underscoring investor interest in infrastructure plays that tackle cross-border healthcare frictions in the region.
Why interoperability matters in Asia
Hospitals and clinics across Asia operate on a patchwork of legacy systems, bespoke hospital information systems, and different data standards. That fragmentation translates into stalled referrals, delayed overseas checkups, and administrative bottlenecks for providers, insurers and patients, especially when care crosses national borders.
“In many cases the records exist, but formats, systems and languages do not match,” said Xiaoyan (Fiona) Zhou, CEO of I.W.G. “Our goal is to make medical information flow as easily and securely as communication on the internet.”
The company cites market research that values global healthcare interoperability solutions at US$3.9 billion in 2024. It projects to reach US$14.7 billion by 2034, with Asia Pacific expected to be the fastest-growing region. That growth is driven by rising cross-border care — medical tourism, overseas checkups and multinational insurers — and uneven digital maturity among providers, which makes plug-and-play solutions rare.
How the product works
I.W.G’s platform does not require hospitals to rip out existing IT. Instead, it ingests documents in multiple formats (PDF, XML, HL7, DICOM, etc.) and uses an AI referral agent to understand clinical context. The agent extracts and maps relevant data into the format required by a receiving institution, reducing the need for bespoke integrations or hardware installs.
Critically for Southeast Asia, the platform handles both language and structural mismatches. The AI can translate and reformat referral documents so that a specialist in Singapore, for instance, can receive and process records from a hospital in Indonesia or Japan with minimal friction.
Also Read: Why Antler is going all-in on Japan’s earliest-stage founders
Beyond format conversion, I.W.G is developing features to check referral content against clinical guidelines and institution-specific protocols automatically. That assists clinicians by reducing manual cross-referencing and the risk of relying on outdated references, a small but meaningful efficiency gain in busy referral pathways.
From radiology roots to cross-border ambition
Founders Zhou and Xiaoxi (Bruce) Guo bring a decade of medical AI experience in Asia. Zhou previously led overseas operations for a China-based AI medical imaging company, navigating hospital deployments and regulatory approvals across multiple markets. The team’s prior work included securing one of the earliest Japanese regulatory clearances for a foreign AI diagnostic solution, an experience that the new investors see as relevant for regional expansion.
“What initially drew us to I.W.G was simple: Fiona and Bruce have already done this once,” said Justin Hall, partner at Golden Gate Ventures. “Their operational depth and early customer retention told us something fundamental about the product and team.”
Antler’s co-founder Jussi Salovaara highlighted the importance of the infrastructure layer: “That infrastructure layer is especially important across Asia, where compatibility, language and workflow differences create enormous friction. It’s exciting to see the team validate their approach through real customer adoption beyond Japan.”
Early traction across Asia
I.W.G says it already has deployments across Japan, China, Singapore and Indonesia. Customers include regional hospitals, community clinics, teleradiology centres, medical tourism firms, and health checkup centres. The company has also seen interest from premium insurers and credit card programs that support overseas medical checkups, services where language barriers and incompatible systems frequently create operational delays.
These early adopters point to a practical, demand-led path for the company. Where many digital-health startups chase flashy diagnostic applications, I.W.G is building the plumbing that lets those applications work across institutions and jurisdictions — a slower, less glamorous but arguably more foundational problem.
Why investors are paying attention
Investors are betting on the network effects of interoperability. If hospitals, insurers, and medical facilitators adopt a common AI-mediated exchange layer, the value of participating increases with each new node on the network. For Southeast Asia, a region defined by diverse languages, differing regulatory regimes, and high cross-border patient flows, such a shared layer could reduce time-to-care and administrative overhead for both private and public providers.
The involvement of Dr Toshihiko Sato, a well-known radiologist and healthtech entrepreneur, gives the startup clinical credibility in Japan and signals clinicians’ willingness to experiment with AI-mediated workflows.
Next steps and challenges
I.W.G plans to use the fresh capital to expand engineering and business development teams, deepen integrations with healthcare providers and enhance multilingual and workflow automation features. The company also points to its participation in the Mayo Clinic Platform Accelerate programme as part of its attempt to align with global clinical standards.
But challenges remain. Interoperability is not just a technical problem; it involves regulatory, contractual and cultural obstacles. Hospitals can be slow to adopt third-party middleware, and data governance regimes vary widely across Asian markets. Success will depend on the startup’s ability to demonstrate measurable time and cost savings, and to navigate local regulations on patient data sharing.
A pragmatic approach
I.W.G’s approach is deliberately incremental: rather than replacing systems, it augments them. That pragmatic posture should make sales conversations easier in markets where hospital IT budgets and regulatory risk-aversion make wholesale change difficult.
Also Read: AI is detecting cancer earlier in Southeast Asia but our policies and capital have not caught up
For Southeast Asian stakeholders, from insurers in Singapore to teleradiology hubs in Indonesia, an AI layer that eases data exchange could be an operationally attractive proposition. If I.W.G can convert pilot projects into long-term contracts, it could carve out a rare regional interoperability footprint that bridges Greater China, Japan and Southeast Asia.
Whether that vision scales will depend on execution: securing larger institutional customers, proving cross-border workflows at scale, and winning over conservative clinical and IT buyers. For now, US$1.8 million gives the Tokyo startup room to iterate and push into markets where the friction of incompatible records is felt most sharply.
The post Japan’s I.W.G raises US$1.8M to stitch Asia’s fractured medical records appeared first on e27.